BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31803290)

  • 1. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
    Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
    J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
    [No Abstract]   [Full Text] [Related]  

  • 2. CD200 expression in B-cell chronic lymphoproliferative disorders.
    El Desoukey NA; Afify RA; Amin DG; Mohammed RF
    J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
    Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
    Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
    Li W; Fang P; Fu G; Liang H; Peng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
    Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
    Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
    Al-Zubaidi HK; Hughes SF
    Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
    [No Abstract]   [Full Text] [Related]  

  • 12. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Sun Y; Wang SA; Sun T
    Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Diagnostic Usefulness of CD200 Expression in B-cell Chronic Lymphoproliferative Disorders.
    Purohit A; Satiza M; Somasundaram V; Sharma R; Mishra P; Seth T; Tyagi S; Mahapatra M; Pati HP; Saxena R
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):684-690. PubMed ID: 37786819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.
    Mehrpouri M; Sadat Hosseini M; Jafari L; Mosleh M; Shahabi Satlsar E
    Iran Biomed J; 2023 Jan; 27(1):15-22. PubMed ID: 36624655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
    Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
    Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
    Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
    Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections.
    Bumbea H; Vladareanu AM; Vintilescu A; Radesi S; Ciufu C; Onisai M; Baluta C; Begu M; Dobrea C; Arama V; Streinu-Cercel A; Arama S
    J Med Life; 2011 Aug; 4(3):256-63. PubMed ID: 22567048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.
    Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA
    Int J Lab Hematol; 2018 Oct; 40(5):533-539. PubMed ID: 29806244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
    Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
    Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
    Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
    Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.